A look at Verily's health tracking watch prototype shows e-ink display, long battery life for more constant tracking, plans to use in medical research studies
Antonio Regalado / MIT Technology Review :
Context & Ripple Effects
Verily's prototype follows a design logic consumer makers have already validated: Withings shipped an e-ink activity tracker back in January 2016 — its $70 Go running eight months on a button cell — and the same month this story broke, Withings' Steel HR stretched battery life to 25–45 days by keeping the screen minimal. Verily is applying that low-power template not to retail shelves but to medical research studies, where weeks of uninterrupted data matter more than notifications.
The stakes are sharpened by Verily's position: per the reported funding round, Alphabet remains an investor but no longer holds a controlling stake, leaving the company with roughly two years of runway to prove its research-hardware thesis on its own.
First-order effects
- Researchers running Verily's studies get a purpose-built instrument whose e-ink display and long battery life enable near-constant tracking instead of the charge-interrupted data gaps typical of bright-screen smartwatches like the OnePlus Watch 2's three-day endurance.
Second-order effects
- Clinical demand is already visible outside controlled studies — some doctors use the Apple Watch to diagnose and manage patient conditions despite approved alternatives — so a research-grade Verily device pressures consumer wearable makers to validate their health data for medical use or cede that ground.
Third-order effects
- Wrist-worn sensing is splitting into two tracks: consumer smartwatches optimizing screens and apps versus research instruments optimizing battery and data continuity, a split Meta's prototype EMG wristband reinforces from the input-peripherals side; if Verily's model holds, study hardware becomes a distinct procurement category with Alphabet's reduced control testing whether it can stand without parent-company subsidy.
The trend: Health wearables are bifurcating into consumer smartwatches and long-battery research instruments built for continuous clinical-grade data collection.